Table I.
Clinical characteristics of all the patients.
| Characteristics | Patients (n=18) |
|---|---|
| Age, median years (range) | 51 (34–83) |
| Gender, no. (%) | |
| Male | 11 (61) |
| Female | 7 (39) |
| ECOG, no. (%) | |
| 0–1 | 3 (17) |
| 2–4 | 15 (83) |
| IELSG, no. (%) | |
| 0–1 | 5 (28) |
| 2–3 | 11 (61) |
| 4–5 | 2 (11) |
| LDH, no. (%) | |
| Normal | 13 (72) |
| Elevated | 5 (28) |
| CSF cytology, no. (%) | |
| Positive | 4 (22) |
| Negative | 14 (78) |
| CSF protein, no. (%) | |
| Normal | 12 (67) |
| Elevated | 6 (33) |
| Pathology, no. (%) | |
| DLBCL | 18 (100) |
ECOG, Eastern Cooperative Oncology Group; IELSG, International Extranodal Lymphoma Study Group; LDH, lactate dehydrogenase; CFS, cerebrospinal fluid; DLBCL, diffuse large B-cell lymphoma.